T1	Participants 91 131	II type mixed essential cryoglobulinemia
T2	Participants 134 351	Thirty-three patients with II type mixed essential cryoglobulinemia (MEC) were randomized into two groups: one to receive combined therapy including prednisone plus interferon, the other to receive prednisone therapy.
T3	Participants 1470 1511	II type mixed essential cryoglobulinemia.
